Literature DB >> 6713539

Modulation of eosinophil cytotoxicity by blood mononuclear cells from healthy subjects and patients with chronic schistosomiasis mansoni.

A J Dessein, H L Lenzi, J C Bina, E M Carvalho, W Y Weiser, Z A Andrade, J R David.   

Abstract

Human blood mononuclear cells in culture release a factor(s) that markedly enhances eosinophil cytotoxicity. This factor(s) stimulates eosinophils to kill Schistosoma mansoni larvae at low antibody concentrations and cell/target ratios. A study of the mononuclear cells of 78 subjects with chronic schistosomiasis mansoni and 33 controls suggests that the production of eosinophil cytotoxicity enhancing activity (ECEA) is suppressed in most patients with S. mansoni infections. Suppression of ECEA production was not observed, however, with cells from many patients with heavy infections, including patients with hepatosplenomegaly. The possible role of ECEA in the development of pathology is discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6713539     DOI: 10.1016/0008-8749(84)90282-x

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  10 in total

1.  Enhancement of leukotriene C4 release from primate airway macrophages by cellular interactions.

Authors:  A M Campbell; S T Harper; C Hallam; E Wells; J Mann; C Robinson
Journal:  Br J Pharmacol       Date:  1989-10       Impact factor: 8.739

2.  Segregation analysis indicates a major gene in the control of interleukine-5 production in humans infected with Schistosoma mansoni.

Authors:  V Rodrigues; L Abel; K Piper; A J Dessein
Journal:  Am J Hum Genet       Date:  1996-08       Impact factor: 11.025

3.  Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni.

Authors:  L Abel; F Demenais; A Prata; A E Souza; A Dessein
Journal:  Am J Hum Genet       Date:  1991-05       Impact factor: 11.025

4.  Plasma membrane antigens on light density and activated human blood eosinophils.

Authors:  P C Tai; D M Bakes; J R Barkans; C J Spry
Journal:  Clin Exp Immunol       Date:  1985-05       Impact factor: 4.330

Review 5.  Thioredoxins, glutaredoxins, and peroxiredoxins--molecular mechanisms and health significance: from cofactors to antioxidants to redox signaling.

Authors:  Eva-Maria Hanschmann; José Rodrigo Godoy; Carsten Berndt; Christoph Hudemann; Christopher Horst Lillig
Journal:  Antioxid Redox Signal       Date:  2013-03-28       Impact factor: 8.401

6.  Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.

Authors:  D S Silberstein; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

7.  Ultrastructure of the attack of eosinophils stimulated by blood mononuclear cell products on schistosomula of Schistosoma mansoni.

Authors:  J P Caulfield; H L Lenzi; P Elsas; A J Dessein
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

8.  Thioredoxin 80-activated-monocytes (TAMs) inhibit the replication of intracellular pathogens.

Authors:  Ximena Cortes-Bratti; Eugénie Bassères; Fabiola Herrera-Rodriguez; Silvia Botero-Kleiven; Giuseppe Coppotelli; Jens B Andersen; Maria G Masucci; Arne Holmgren; Esteban Chaves-Olarte; Teresa Frisan; Javier Avila-Cariño
Journal:  PLoS One       Date:  2011-02-18       Impact factor: 3.240

Review 9.  Inflammation, Oxidative Stress, Senescence in Atherosclerosis: Thioredoxine-1 as an Emerging Therapeutic Target.

Authors:  Khadija El Hadri; Rémy Smith; Eric Duplus; Chahrazade El Amri
Journal:  Int J Mol Sci       Date:  2021-12-22       Impact factor: 5.923

Review 10.  Cell stress proteins in atherothrombosis.

Authors:  Julio Madrigal-Matute; Roxana Martinez-Pinna; Carlos Ernesto Fernandez-Garcia; Priscila Ramos-Mozo; Elena Burillo; Jesus Egido; Luis Miguel Blanco-Colio; Jose Luis Martin-Ventura
Journal:  Oxid Med Cell Longev       Date:  2012-06-25       Impact factor: 6.543

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.